ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,222, issued on Sept. 15, was assigned to Talengen International Ltd. (Hong Kong).
"Method and medicine for treating Huntington's disease" was invented by Jinan Li (Beijing).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a method and drug for treating Huntington's disease, which includes: administering a therapeutically effective amount of a component of a plasminogen activation pathway or a related compound thereof to a subject. Also provided are a drug, pharmaceutical composition, product, and kit used for treating Huntington's disease and containing the above component or compound."
The patent was filed on March 24, 2021, under Appli...